Investing Profile

David Adair

Photo of David Adair, Managing Director at Solas BioVentures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Solas BioVentures Managing Director
8
CompanyStageDateRound SizeTotal Raised
Vektor Medical
Series AFeb 2024$16M
$16M
Arrivo BioVentures LLC
Series BNov 2023$45M
$45M
EirSystems
SeedAug 2022
Stimdia Medical
Series BJul 2022$16M
$16M
Cryosa
Series BSep 2021$22M
$32M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds)
Francis Medical
Series BSep 2021$55M
$55M
Co-investors: Jan Garfinkle (Arboretum Ventures)
InterShunt
Series UnknownJan 2021$3M
$3M
Knopp Biosciences
Series CNov 2020$14M
$14M